Advanced Search Results For "PREVENTION"
Your filters
Disruptive Innovation in CVD Primary Prevention: Assessing the Equivalency for Secondary Prevention Strategies.
Publication Type: Editorial & Opinion
Source(s): JACC. Cardiovascular imaging [JACC Cardiovasc Imaging] 2023 Sep; Vol. 16 (9), pp. 1190-1192. Date of Electronic Publication: 2023 Jul 12.
Abstract: Competing Interests: Funding Support and Author Disclosures Dr Leucker has received research grant funding from Amgen and Merck, which is not relevant to this manuscript. Dr Blumenthal has reported that he has no relationships relevant to the contents ...
Association Between Child Access Prevention and State Firearm Laws With Pediatric Firearm-Related Deaths.
Publication Type: Academic Journal
Source(s): The Journal of surgical research [J Surg Res] 2023 Jan; Vol. 281, pp. 223-227. Date of Electronic Publication: 2022 Oct 04.
Abstract: Introduction: We aim to study the association between state child access prevention (CAP) and overall firearm laws with pediatric firearm-related mortality.Methods: The Centers for Disease Control and Prevention Web-based Injury Statistics Query and Re...
A trauma-informed approach to suicide prevention for the COVID-19 pandemic.
Publication Type: Academic Journal
Source(s): Psychiatry research [Psychiatry Res] 2023 Sep; Vol. 327, pp. 115407. Date of Electronic Publication: 2023 Aug 06.
Abstract: During the COVID-19 pandemic, researchers have questioned how the devastation of the pandemic might impact suicide rates. While initial evidence on suicide rates during the early stages of the pandemic is mixed, there are signs we should still remain v...
Sodium-Glucose Cotransporter-2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease: A Meta-Analysis of Randomized Trials and Systematic Review.
Publication Type: Academic Journal
Source(s): Journal of the American Heart Association [J Am Heart Assoc] 2023 Aug 15; Vol. 12 (16), pp. e030578. Date of Electronic Publication: 2023 Aug 10.
Abstract: Background Sodium-glucose cotransporter-2 (SGLT2) inhibitors reduce atherosclerotic cardiovascular disease (ASCVD) events in patients with prior ASCVD and type 2 diabetes; however, this benefit is uncertain in patients without established ASCVD. Method...
Rate of Change in 10-Year Atherosclerotic Cardiovascular Disease Risk and Its Implications for Primary Prevention.
Publication Type: Academic Journal
Source(s): Hypertension (Dallas, Tex. : 1979) [Hypertension] 2023 Aug; Vol. 80 (8), pp. 1697-1706. Date of Electronic Publication: 2023 May 31.
Abstract: Background: Contemporary cardiovascular primary prevention is based on the assessment of the 10-year risk of atherosclerotic cardiovascular disease (ASCVD). However, the clinical implications of temporal change in the 10-year ASCVD risk estimate (∆10-y...
Current approaches to secondary prevention after hip fracture in England and Wales - an analysis of trends between 2016 and 2020 using the National Hip Fracture Database (NHFD).
Publication Type: Academic Journal
Source(s): Archives of osteoporosis [Arch Osteoporos] 2023 Jul 10; Vol. 18 (1), pp. 93. Date of Electronic Publication: 2023 Jul 10.
Abstract: Hip fractures are strong risk factors for further fractures. However, using the National Hip Fracture Database, we observed that in England and Wales, 64% of patients admitted on oral bisphosphonates were discharged on the same and injectable drug use ...
The Scope of Practice for Primary Cardiovascular Disease Prevention Expanded to Advanced Practice Providers: What Does the Data Show?
Publication Type: Academic Journal
Source(s): Current cardiology reports [Curr Cardiol Rep] 2023 Jul; Vol. 25 (7), pp. 735-746. Date of Electronic Publication: 2023 Jun 07.
Abstract: Purpose of Review: The review aims to explore the available literature on the role of advance practice providers (APPs) in the primary prevention of cardiovascular diseases (CVD).Recent Findings: CVD are the major cause of death and disease with the gr...
Relapse prevention through health technology program reduces hospitalization in schizophrenia.
Publication Type: Academic Journal
Source(s): Psychological medicine [Psychol Med] 2023 Jul; Vol. 53 (9), pp. 4114-4120. Date of Electronic Publication: 2022 May 30.
Abstract: Background: Psychiatric hospitalization is a major driver of cost in the treatment of schizophrenia. Here, we asked whether a technology-enhanced approach to relapse prevention could reduce days spent in a hospital after discharge.Methods: The Improvin...
Embolic Stroke of Undetermined Source: Role of Implantable Loop Recorder in Secondary Prevention.
Publication Type: Academic Journal
Source(s): The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques [Can J Neurol Sci] 2023 Jul; Vol. 50 (4), pp. 529-534. Date of Electronic Publication: 2022 Jun 03.
Abstract: Background and Aims: Atrial fibrillation (AF) is the most important cause of embolic stroke of undetermined source (ESUS). Implantable loop recorder (ILR) demonstrated the highest sensitivity for detecting it. This register was created to confirm the h...
Stroke Prevention.
Source(s): American family physician [Am Fam Physician] 2023 Jul; Vol. 108 (1), pp. Online.